Swiss National Bank
SRNE

Swiss National Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Swiss National Bank’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,086,400
Closed -$963K – 2701
2022
Q4 		$963K Buy
1,086,400
+164,100
+18% +$218K ﹤0.01% 2367
2022
Q3 		$1.45M Buy
922,300
+218,300
+31% +$495K ﹤0.01% 2096
2022
Q2 		$1.42M Buy
704,000
+15,900
+2% +$27.5K ﹤0.01% 2156
2022
Q1 		$1.6M Buy
688,100
+64,900
+10% +$202K ﹤0.01% 2160
2021
Q4 		$2.9M Buy
623,200
+19,900
+3% +$124K ﹤0.01% 1811
2021
Q3 		$4.6M Buy
603,300
+16,300
+3% +$138K ﹤0.01% 1518
2021
Q2 		$5.69M Buy
587,000
+76,400
+15% +$608K ﹤0.01% 1415
2021
Q1 		$4.22M Buy
510,600
+20,400
+4% +$215K ﹤0.01% 1564
2020
Q4 		$3.35M Buy
490,200
+192,400
+65% +$1.55M ﹤0.01% 1612
2020
Q3 		$3.32M Buy
297,800
+34,600
+13% +$317K ﹤0.01% 1433
2020
Q2 		$1.65M Buy
+263,200
New +$1.01M ﹤0.01% 1821
2019
Q4 		– Sell
-178,300
Closed -$382K – 2552
2019
Q3 		$382K Hold
178,300
– – ﹤0.01% 2421
2019
Q2 		$476K Hold
178,300
– – ﹤0.01% 2426
2019
Q1 		$847K Buy
178,300
+13,200
+8% +$34.6K ﹤0.01% 2155
2018
Q4 		$396K Buy
165,100
+46,200
+39% +$151K ﹤0.01% 2425
2018
Q3 		$523K Hold
118,900
– – ﹤0.01% 2400
2018
Q2 		$856K Buy
+118,900
New +$809K ﹤0.01% 2256
2017
Q2 		– Sell
-75,764
Closed -$299K – 2575
2017
Q1 		$299K Hold
75,764
– – ﹤0.01% 2487
2016
Q4 		$371K Buy
+75,764
New +$455K ﹤0.01% 2483

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Swiss National Bank's SRNE Position: Q1 2023 in Review

Swiss National Bank sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 1,086,400 shares — an estimated $963K sold.

Swiss National Bank first reported a position in SRNE in Q4 2016 and held it in 19 quarters. The position peaked at $5.69M in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Swiss National Bank reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 1,086,400 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $963K.
  • Swiss National Bank first reported a position in Sorrento Therapeutics, Inc. in Q4 2016 and held it in 19 quarters.
  • Swiss National Bank's Sorrento Therapeutics, Inc. position peaked at $5.69M in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.